MSMEG2299
ms2299
-
M. smegmatis · MC2-155
MC2-155 Coordinates: 2381113 – 2383233
Vulnerability Index (VI):
M. tuberculosis homologs nrdE
M. abscessus homologs MAB3413c
background  +5   0  -5 -10 -15 sgRNA L2FC (+ATc/–ATc) TnSeq Gene Essentiality Predictions (1, 2) Essential Growth Defect Non-Essential Growth Advantage Unknown Operon Legend (3) Operon (1) PMID: 28096490 (2) PMID: 31388080 (3) PMID: 26536359 dinB MSMEG2295 MSMEG2296 MSMEG2297 MSMEG2299 MSMEG2301 MSMEG2302 MSMEG2303
Click the tabs above to view different types of data for this gene. The Vulnerability tab shows CRISPRi fitness data.
DNA and Protein Sequence help

DNA Sequence

>ms2299_MSMEG2299_dna
CCGGACATCAACGCTGGGGGCTACGTCCCCAAGCAGGTCATCGCGTTCCTCAACAACGAACACAACCGGTCGTTGATCCGCGGCGTCATCGCCGCGGGCAACAACAACTTCGGTGCGGAGTTCGCCTATGCGGGCAATGTGATCGCGCGCAAGTGTGGCGTGCCGTACCTGTATCGCTTCGAACTGATGGGTACCCCGGACGATGTGGAAGCCGTCCGGGCAGGTTTGAAAGACTTCTGGAAGGAACAGACGTGCCACCCACCGTCACAGCTGCAGAGCCTGTAACCACCACCGGGCACGTGTTGCCGGGGGAGGCGGATTACCACGCGCTCAACGCGATGCTGAATCTGTACGACGCCGACGGCAAGATTCAGTTCGAAAAGGACAGGGAAGCCGCCAAGCAGTACTTCCTGCAGCACGTCAACCAGAACACGGTCTTCTTCCACAGCCAGGACGAGAAGCTCGACTACCTGATCGAGAACGAGTACTACGAGCGCGAGGTGCTCGACCAGTACTCCCGCGACTTCATCAAGAGCCTGCTGGACCGCGCGTACGCCAAGAAGTTTCGGTTCCCCACGTTCCTCGGTGCGTTCAAGTACTACACGTCCTACACGCTGAAGACCTTCGACGGTAAGCGCTACCTGGAGCGTTTCGAGGACCGCGTCGTCATGGTCGCGTTGACCCTGGCCGCAGGCGACACCGAACTCGCCGAGAAACTCGTCGACGAGATCATCGACGGCCGGTTCCAGCCGGCCACCCCCACGTTCCTCAACTCGGGCAAGAAGCAGCGCGGCGAGCCGGTGTCCTGCTTCCTGTTGCGCATCGAGGACAACATGGAGTCCATCGGGCGTTCCATCAACTCGGCGCTGCAGCTGTCCAAGCGCGGCGGCGGAGTCGCGCTGCTGCTGAGCAACATCCGCGAGCACGGCGCGCCCATCAAGAACATCGAGAACCAGAGCTCGGGCGTCATCCCCATCATGAAGCTGCTGGAGGACTCGTTCTCCTACGCCAATCAGCTGGGTGCCCGTCAGGGCGCGGGCGCGGTGTACCTGCACGCCCACCACCCCGACATCTACCGGTTCCTGGACACCAAGCGCGAGAACGCCGACGAGAAGATCCGGATCAAGACGCTCTCGCTGGGTGTCGTGATCCCCGACATCACCTTCGAGCTGGCCAAGAAGAACGAGGACATGTACCTGTTCTCGCCGTACGACGTCGAGCGCGTCTACGGGGTGCCGTTCGCCGACGTCTCGGTCACCGAGAAGTACTACGAGATGGTCGACGACGCGCGGATCCGCAAGACCAAGATCAACGCGCGCGAGTTCTTCCAGACGCTGGCCGAGCTGCAGTTCGAATCGGGCTACCCGTACATCATGTTCGAGGACACCGTGAACCGGTCCAACCCGATCGCGGGCAAGATCACGCACTCGAACCTGTGCTCGGAGATCCTGCAGGTCTCCACGCCGTCGGAGTTCAACGACGACCTGTCCTACGCCAAGGTGGGCAAGGACATCTCCTGCAACCTCGGCTCGCTCAACATCGCCAAGGCCATGGACTCGCCGGACTTCGCGCAGACCATCGAGGTGGCGATCCGTGCGCTCACCGCGGTGAGCGATCAGACCCACATCACGTCCGTGCCGTCGATCGAGCAGGGCAACAACGATTCCCACGCCATCGGCCTGGGGCAGATGAACCTGCACGGATACCTTGCGCGGGAACGCATCTACTACGGTTCCGAAGAGGGCATCGACTTCACGAACATCTACTTCTACACGGTGCTGTTCCACGCGCTGCGCGCGTCGAACAAGATCGCGATCGAGCGCGGGACGCACTTCAAGGGATTCGAGAAGTCCAAGTACGCCTCGGGCGAGTTCTTCGACAAGTACACCGATCAGGTGTGGGAGCCCAAGACCGACAAGGTGCGCCGGCTGTTCGCCGACGCCGATATCCACATCCCCACGCAGGACGACTGGAAGCAGTTGAAGGAGTCGGTGCAGAAGCACGGCATCTACAACCAGAACCTGCAGGCCGTCCCGCCGACGGGGTCGATCTCCTACATCAACCACTCGACGTCGTCGATCCACCCGGTCGCGTCGAAGATCGAGATCCGCAAGGAAGGCAAGATCGGTCGCGTCTACTACCCGGCGCCGTACATGACCAACGACAACCTGGACTACTACCAGGACGCGTATGAGATCGGGTACGAGAAGATCATCGACACCTACGCCGCGGCCACCCAGCACGTGGACCAGGGTCTGAGCCTGACGTTGTTCTTCAAGGACACCGCCACCACGCGTGACGTGAACAAGGCCCAGATCTACGCATGGCGCAAGGGCATCAAGACGCTCTACTACATCCGCCTGCGCCAGATGGCCTTGGAGGGAACCGAAGTCGAGGGTTGCGTCAGCTGCATGCTGTGA

Protein Sequence

>Ms2299_MSMEG2299_protein
VLPGEADYHALNAMLNLYDADGKIQFEKDREAAKQYFLQHVNQNTVFFHSQDEKLDYLIENEYYEREVLDQYSRDFIKSLLDRAYAKKFRFPTFLGAFKYYTSYTLKTFDGKRYLERFEDRVVMVALTLAAGDTELAEKLVDEIIDGRFQPATPTFLNSGKKQRGEPVSCFLLRIEDNMESIGRSINSALQLSKRGGGVALLLSNIREHGAPIKNIENQSSGVIPIMKLLEDSFSYANQLGARQGAGAVYLHAHHPDIYRFLDTKRENADEKIRIKTLSLGVVIPDITFELAKKNEDMYLFSPYDVERVYGVPFADVSVTEKYYEMVDDARIRKTKINAREFFQTLAELQFESGYPYIMFEDTVNRSNPIAGKITHSNLCSEILQVSTPSEFNDDLSYAKVGKDISCNLGSLNIAKAMDSPDFAQTIEVAIRALTAVSDQTHITSVPSIEQGNNDSHAIGLGQMNLHGYLARERIYYGSEEGIDFTNIYFYTVLFHALRASNKIAIERGTHFKGFEKSKYASGEFFDKYTDQVWEPKTDKVRRLFADADIHIPTQDDWKQLKESVQKHGIYNQNLQAVPPTGSISYINHSTSSIHPVASKIEIRKEGKIGRVYYPAPYMTNDNLDYYQDAYEIGYEKIIDTYAAATQHVDQGLSLTLFFKDTATTRDVNKAQIYAWRKGIKTLYYIRLRQMALEGTEVEGCVSCML

Essentiality:

Call Condition Type Source Notes
Unknown in vitro CRISPRi [Bosch & DeJesus et al. (2021)]
Growth Advantage in vitro TnSeq [Dragset et al. (2019)]

You do not have permission to view notes.